Fenofibrate appears to be an effective and safe drug for the treatment of neonatal hyperbilirubinemia. It has been proven that it decreases the duration of phototherapy and thus shortens the length of hospital stay.
This study was performed to study the prophylactic role of fenofibrate in prevention of neonatal jaundice.